Seth Lederman - Net Worth and Insider Trading

Seth Lederman Net Worth

The estimated net worth of Seth Lederman is at least $175,306 dollars as of 2025-07-24. Seth Lederman is the CEO of Tonix Pharmaceuticals Holding Corp and owns about 4,007 shares of Tonix Pharmaceuticals Holding Corp (TNXP) stock worth over $175,306. Details can be seen in Seth Lederman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Seth Lederman has not made any transactions after 2025-05-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Seth Lederman

To

Seth Lederman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Seth Lederman owns 1 companies in total, including Tonix Pharmaceuticals Holding Corp (TNXP) .

Click here to see the complete history of Seth Lederman’s form 4 insider trades.

Insider Ownership Summary of Seth Lederman

Ticker Company Transaction Date Type of Owner
TNXP Tonix Pharmaceuticals Holding Corp 2025-05-15 director & 10 percent owner & Chief Executive Officer

Seth Lederman Latest Holdings Summary

Seth Lederman currently owns a total of 1 stock. Seth Lederman owns 4,007 shares of Tonix Pharmaceuticals Holding Corp (TNXP) as of May 15, 2025, with a value of $175,306.

Latest Holdings of Seth Lederman

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TNXP Tonix Pharmaceuticals Holding Corp 2025-05-15 4,007 43.75 175,306

Holding Weightings of Seth Lederman


Seth Lederman Form 4 Trading Tracker

According to the SEC Form 4 filings, Seth Lederman has made a total of 7 transactions in Tonix Pharmaceuticals Holding Corp (TNXP) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Tonix Pharmaceuticals Holding Corp is the acquisition of 4,000 shares on May 15, 2025, which cost Seth Lederman around $86,200.

Insider Trading History of Seth Lederman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Seth Lederman Trading Performance

GuruFocus tracks the stock performance after each of Seth Lederman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Seth Lederman is -19.93%. GuruFocus also compares Seth Lederman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Seth Lederman within 3 months outperforms 11 times out of 30 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Seth Lederman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Seth Lederman

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 30 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -5.23 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -7.8 LIMIT LIMIT LIMIT LIMIT LIMIT

Seth Lederman Ownership Network

Ownership Network List of Seth Lederman

No Data

Ownership Network Relation of Seth Lederman

Insider Network Chart


Seth Lederman Owned Company Details

What does Tonix Pharmaceuticals Holding Corp do?

Who are the key executives at Tonix Pharmaceuticals Holding Corp?

Seth Lederman is the director & 10 percent owner & Chief Executive Officer of Tonix Pharmaceuticals Holding Corp. Other key executives at Tonix Pharmaceuticals Holding Corp include Chief Medical Officer Gregory M Sullivan , Chief Administrative Officer Jessica Edgar Morris , and Chief Financial Officer Bradley Saenger .

Tonix Pharmaceuticals Holding Corp (TNXP) Insider Trades Summary

Over the past 18 months, Seth Lederman made 1 insider transaction in Tonix Pharmaceuticals Holding Corp (TNXP) with a net purchase of 4,000.

In summary, during the past 3 months, insiders sold 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) in total and bought 4,000 shares, with a net purchase of 4,000 shares. During the past 18 months, 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) were sold and 4,000 shares were bought by its insiders, resulting in a net purchase of 4,000 shares.

Tonix Pharmaceuticals Holding Corp (TNXP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Tonix Pharmaceuticals Holding Corp Insider Transactions

No Available Data

Seth Lederman Mailing Address

Above is the net worth, insider trading, and ownership report for Seth Lederman. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Seth Lederman's mailing address is: New York Ny 10022.